Results 41 to 50 of about 300,331 (272)

Concentrations of Cysteinyl Leukotrienes in Various Biological Fluids of Children with Bronchial Asthma, Atopic Dermatitis and Food Protein Induced Enterocolitis [PDF]

, 2019
Clinical manifestation of food allergy is characterized by polymorphic cutaneous, respiratory and gastrointestinal syndromes. Leukotrienes occupy a key place in the pathogenesis of a wide range of inflammatory diseases, including bronchial asthma ...
Haiduchyk, H. (Halyna), Shadrin, O. (Oleg)   +1 more
core   +3 more sources

Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

Allergy. European Journal of Allergy and Clinical Immunology, 2020
Atopic dermatitis (AD) is a common inflammatory skin condition that has traditionally been considered a paradigmatic type 2 immunity (T2)‐driven disease.
T. Bieber
semanticscholar   +1 more source

Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

Expert review of pharmacoeconomics & outcomes research, 2020
Introduction Asthma, allergic rhinitis, atopic dermatitis, and food allergy affect approximately 20% of the global population. Few studies describe the burden of the totality of these diseases and only a handful studies provide a comprehensive overview ...
B. Dierick, T. van der Molen, B. M. J. Flokstra‐de Blok, A. Muraro, M. Postma, J. Kocks, Job F. M. van Boven   +6 more
semanticscholar   +1 more source

Brain processing of contagious itch in patients with atopic dermatitis [PDF]

, 2017
Several studies show that itch and scratching cannot only be induced by pruritogens like histamine or cowhage, but also by the presentation of certain (audio-) visual stimuli like pictures on crawling insects or videos showing other people scratching ...
Apkarian, Bae, Buccino, Buccino, Calvo-Merino, Cavanna, Chrostowska-Plak, Evers, Farrow, Fried, Garcia-Larrea, Hanifin, Harsay, Holle, Iacoboni, Ishiuji, Knotkova, Krakauer, Lavery, Lloyd, Mochizuki, Mochizuki, Mochizuki, Mochizuki, Mochizuki, Mochizuki, Niemeier, Palombo, Papoiu, Papoiu, Papoiu, Plassmann, Platek, Savin, Schneider, Schut, Schut, Schut, Schut, Smolke, Ständer, Ständer, Yosipovitch, Yosipovitch, Yosipovitch   +44 more
core   +3 more sources

Key Trends and Insights in Smart Polymeric Skin Wearable Patches

Advanced Engineering Materials, EarlyView.
Intelligent polymers, which respond to various physical and biological stimuli, are explored for the development of skin wearable patches in biomedical applications. Smart polymers, also known as intelligent or stimuli‐responsive polymers, play a crucial role in the development of advanced wearable patches due to their versatility and softness.
Sergio J. Peñas‐Núñez, Rajat Rai, Miryam Criado‐Gonzalez   +2 more
wiley   +1 more source

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases [PDF]

, 2004
Fluticasone propionate - the first carbothioate corticosteroid - has been classified as a potent anti-inflammatory drug for dermatological use. It is available as 0.05% cream and 0.005% ointment formulations for the acute and maintenance treatment of ...
Atsuta J, Boner AL, Bridgman A, Callen J, Delescluse J, Dooms-Goossens AE, Dykes PJ, Falcoz C, Fisher DA, Goossens A, Harding SM, Hogger P, James M, Johnson M, Johnson M, Juhlin L, Katz HI, Korting HC, Lebwohl M, Li JT, Liu XQ, Llewellyn-Jones CG, Lucky AW, McKenzie AW, McLean HM, Nurnberger FG, Phillipps GH, Roberts DT, Spencer CM, Tharp MD, Venning VA, Wilkinson SM, Wolkerstorfer A, Young MMR   +33 more
core   +1 more source

Atopic dermatitis

Allergy, Asthma & Clinical Immunology
Abstract Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life (QoL) of affected individuals as well as their families. Although the pathogenesis of the disorder is not yet completely understood, it appears to result from the complex interplay between defects in skin barrier function ...
Stuart Carr, Rebecca Pratt, Fred White, Wade Watson   +3 more
openaire   +3 more sources

Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.

New England Journal of Medicine, 2020
BACKGROUND Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis.
K. Kabashima, T. Matsumura, Hiroshi Komazaki, M. Kawashima   +3 more
semanticscholar   +1 more source

Coordinated Development of Immune Cell Populations in Vascularized Skin Organoids from Human Induced Pluripotent Stem Cells

Advanced Healthcare Materials, EarlyView.
Vascularized skin organoids are developed from human induced pluripotent stem cells and contain macrophages, Langerhans cells, and neutrophils. Vascularized skin organoids offer a transformative platform to model skin biology and enable mechanistic investigations of inflammatory and hematologic skin disorders.
Mitchell Mostina, Jane Sun, Seen Ling Sim, Imaan A. Ahmed, Fernando Souza‐Fonesca‐Guimaraes, Ernst J. Wolvetang, Jason Brown, Snehlata Kumari, Kiarash Khosrotehrani, Abbas Shafiee   +9 more
wiley   +1 more source

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

British Journal of Dermatology, 2020
Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin‐13, a key driver of atopic dermatitis (AD).
J. Silverberg, D. Toth, T. Bieber, Andrew F. Alexis, B. Elewski, A. Pink, D. Hijnen, T. N. Jensen, B. Bang, C. Olsen, A. Kurbasic, S. Weidinger   +11 more
semanticscholar   +1 more source